We are live on ! Find out more
CNTA

Centessa Pharmaceuticals
CNTA

Delisted

CNTA was delisted on the 23rd of June, 2026.

Back to rankings

47 hedge funds and large institutions have $808M invested in Centessa Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 7

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

18% more funds holding

Funds holding: 40 → 47 (+7)

16.64% more ownership

Funds ownership: 63.31% → 79.95% (+17%)

15% less capital invested

Capital invested by funds: $947M → $808M (-$140M)

Holders
47
Holders Change
+7
Holders Change %
+17.5%
% of All Funds
0.72%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
15
Increased
19
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$10.7M
2
CAM
Cormorant Asset Management
Massachusetts
+$10.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.79M
4
BI
BVF Inc
California
+$6.12M
5
BlackRock
BlackRock
New York
+$3.86M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$8.27M
2
Millennium Management
Millennium Management
New York
-$5.63M
3
Jennison Associates
Jennison Associates
New York
-$4.95M
4
Franklin Resources
Franklin Resources
California
-$4.66M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$3.83M -$128K -9,483 -3%
BlackRock
27
BlackRock
New York
$3.23M +$3.86M +287,238 New
KCM
28
Kynam Capital Management
New Jersey
$2.69M +$3.22M +239,041 New
Fidelity Investments
29
Fidelity Investments
Massachusetts
$1.06M -$3.61M -268,437 -74%
Bank of America
30
Bank of America
North Carolina
$892K +$1.03M +76,446 +2,731%
Verition Fund Management
31
Verition Fund Management
Connecticut
$563K +$673K +50,000 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$374K – – –
NFGH
33
Nan Fung Group Holdings
Hong Kong
$250K +$299K +22,200 New
VEA
34
Virtus ETF Advisers
New York
$167K +$199K +14,798 New
Morgan Stanley
35
Morgan Stanley
New York
$158K +$86.9K +6,455 +85%
GSEP
36
Golden State Equity Partners
California
$156K +$187K +13,870 New
GTCM
37
Gyon Technologies Capital Management
New Jersey
$117K +$140K +10,426 New
Northern Trust
38
Northern Trust
Illinois
$100K +$120K +8,884 New
CLOS
39
Compagnie Lombard Odier SCmA
Switzerland
$66K +$41.3K +3,070 +112%
JP Morgan Chase
40
JP Morgan Chase
New York
$51K +$36.1K +2,681 +147%
Citigroup
41
Citigroup
New York
$12K +$11K +820 +392%
TRCT
42
Tower Research Capital (TRC)
New York
$10K +$10.9K +811 +682%
Osaic Holdings
43
Osaic Holdings
Arizona
$9K +$10.1K +750 New
CSS
44
Cubist Systematic Strategies
Connecticut
$7K +$5.81K +432 +216%
UBS Group
45
UBS Group
Switzerland
$6K +$3.7K +275 +124%
ATC
46
Adirondack Trust Company
New York
$5K +$5.38K +400 New
SOW
47
State of Wyoming
Wyoming
$1K +$511 +38 +165%
Millennium Management
48
Millennium Management
New York
– -$5.63M -337,002 Closed
Jennison Associates
49
Jennison Associates
New York
– -$4.95M -296,456 Closed
CCM
50
CAAS Capital Management
New York
– -$1.04M -62,500 Closed
1
2
3

CNTA Hedge Fund Activity: Q4 2021 in Review

47 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Centessa Pharmaceuticals (CNTA) for Q4 2021, worth a combined $808M — down 15% from $947M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CNTA positions and 8 closed out — a net gain of 7 holders — while 19 added to existing stakes and 7 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $10.7M. The largest seller was Logos Global Management, cutting an estimated $8.27M.

  • 47 institutional investors held Centessa Pharmaceuticals (CNTA) as of Q4 2021, up from 40 in Q3 2021.
  • Funds reported $808M of Centessa Pharmaceuticals stock for Q4 2021, down 15% quarter-over-quarter.
  • 15 funds opened new Centessa Pharmaceuticals positions in Q4 2021 and 8 closed out, a net change of +7 holders.
  • The largest Centessa Pharmaceuticals buyer in Q4 2021 was Point72 Asset Management, an estimated $10.7M added.
  • The largest Centessa Pharmaceuticals seller in Q4 2021 was Logos Global Management, an estimated $8.27M sold.

Based on aggregated 13F filings for Q4 2021.